[1]
J. Hynes, S. Basheer O'Dwyer, and M. Lynch, “Clinical and Quality-of-Life Outcomes of Omalizumab Treatment in Chronic Spontaneous Urticaria”, Ir Med J, vol. 119, no. 6, p. 103, Jun. 2026.